Press Releases

NASHVILLE, Tenn. , May 11, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc.   (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and first quarter 2021 financial results. Net revenues from continuing operations during the quarter were $10.5 million , a

NASHVILLE, Tenn. , May 4, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc.   (NASDAQ: CPIX) announced today that it will release first quarter 2021 financial results and Company update after the market closes on Tuesday, May 11, 2021 . A conference call and live internet webcast will be held

ASHVILLE, Tenn. (March 15, 2021) – Cumberland Emerging Technologies, Inc. (CET) announced today the addition of Van Tucker to its board of directors. The mission of CET is to develop innovative new biomedical products emerging from university-based research.

NASHVILLE, Tenn. , March 9, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc.   (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology and rheumatology, today announced fourth quarter and full year 2020 financial results.

NASHVILLE, Tenn. , March 2, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2020 financial results and Company update after the market closes on Tuesday, Mar. 9, 2021 .

NASHVILLE, Tenn. , Nov. 17, 2020 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a U.S. specialty pharmaceutical company, announced today the launch of RediTrex ® (methotrexate) injection. RediTrex is a new line of pre-filled syringes specifically designed for ease of handling and

NASHVILLE, Tenn. , Nov. 10, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and third quarter 2020 financial results. Net revenues from continuing operations during the quarter were $9.3 million .

NASHVILLE, Tenn. , Nov. 3, 2020 /PRNewswire/ --  Cumberland Pharmaceuticals Inc.   (NASDAQ: CPIX) announced today that it will release third quarter 2020 financial results and Company update after the market closes on Tuesday, Nov. 10, 2020 . A conference call and live internet webcast will be held

NASHVILLE, Tennessee (October 5, 2020) – Cumberland Emerging Technologies, Inc.
(CET)

NASHVILLE, Tenn. , Aug. 18, 2020 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced the results of a new review of clinical studies evaluating Caldolor ® ( ibuprofen ) Injection, which was published in the journal Clinical